TORONTO, March 06, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI; OTCQB: CNVIF) (“Conavi Medical” or the “Company”), a commercial stage medical device company focused on designing, ...

Leadership Team Expanded to Support U.S. Commercial Launch and Operational Scale-Up Company Advances Manufacturing, Conference Visibility, and Launch Readiness TORONTO, Dec. 29, 2025 (GLOBE NEWSWIRE) ...

Titan Medical has found its path forward after reporting in 2022 that it would review strategic options citing cash concerns and limited access to new capital. Titan announced yesterday that Toronto, ...

TORONTO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, ...

TORONTO, April 23, 2026 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (“Conavi” or the “Company”) (TSXV: CNVI; OTCQB: CNVIF), a commercial-stage medical device company focused on designing, manufacturing, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Conavi ...

TORONTO--(BUSINESS WIRE)--Conavi Medical Inc. (www.conavi.com) is pleased to announce that it has received a Health Canada Medical Device License for the Novasight ...

As previously announced, on October 8, 2024, Conavi completed a concurrent private placement of subscription receipts (“Subscription Receipts”) for gross proceeds of US$7.7 million (the “Offering”).

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Conavi Medical ( (TSE:CNVI)) has shared ...

– Completed first quarter as a public company and raised $10.6 mil CAD concurrent with listing – Next-generation Novasight design freeze completed on schedule, usability testing and system validation ...